First-in-Class ADC Has Benefit Across mTNBC Subgroups ...Middle East

Medscape - News
For women with pretreated metastatic triple-negative breast cancer (mTNBC), sacituzumab govitecan improved outcomes regardless of target protein expression and BRCA1/2 status, a post-trial analysis shows. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( First-in-Class ADC Has Benefit Across mTNBC Subgroups )

Apple Storegoogle play

Also on site :